CN110430869A - 直肠泡沫配制物 - Google Patents

直肠泡沫配制物 Download PDF

Info

Publication number
CN110430869A
CN110430869A CN201780086722.5A CN201780086722A CN110430869A CN 110430869 A CN110430869 A CN 110430869A CN 201780086722 A CN201780086722 A CN 201780086722A CN 110430869 A CN110430869 A CN 110430869A
Authority
CN
China
Prior art keywords
formulation
foam
propellant
anhydrous
gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780086722.5A
Other languages
English (en)
Chinese (zh)
Inventor
C.C.拉森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of CN110430869A publication Critical patent/CN110430869A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201780086722.5A 2016-12-16 2017-12-14 直肠泡沫配制物 Pending CN110430869A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662435265P 2016-12-16 2016-12-16
US62/435265 2016-12-16
PCT/IB2017/057954 WO2018109717A1 (en) 2016-12-16 2017-12-14 Rectal foam formulations

Publications (1)

Publication Number Publication Date
CN110430869A true CN110430869A (zh) 2019-11-08

Family

ID=60937825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780086722.5A Pending CN110430869A (zh) 2016-12-16 2017-12-14 直肠泡沫配制物

Country Status (12)

Country Link
US (1) US20190351060A1 (https=)
EP (1) EP3554473A1 (https=)
JP (2) JP2020503296A (https=)
KR (1) KR20190110092A (https=)
CN (1) CN110430869A (https=)
AU (1) AU2017377017A1 (https=)
BR (1) BR112019012122A2 (https=)
CA (1) CA3046938A1 (https=)
IL (1) IL267347A (https=)
MX (2) MX391415B (https=)
RU (1) RU2757275C2 (https=)
WO (1) WO2018109717A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3216267A1 (en) * 2021-04-22 2022-10-27 Glenn W. Laub Foam compositions for treating clostridioides difficile infections

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449520A (en) * 1990-07-27 1995-09-12 Giuliani S.P.A. Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
US5725872A (en) * 1993-12-14 1998-03-10 Ferring Bv Composition for foams, notably rectal foams, and foams thus obtained
US20060275221A1 (en) * 2005-05-09 2006-12-07 Foamix Ltd. Saccharide foamable compositions
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
WO2009150530A2 (en) * 2008-06-11 2009-12-17 Ferring International Center Sa Novel foam composition
US20110172222A1 (en) * 2008-07-04 2011-07-14 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the Treatment of Inflammatory Conditions of the Gastrointestinal Tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
SE9000485D0 (sv) * 1990-02-09 1990-02-09 Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
EP1663148A2 (en) * 2003-08-25 2006-06-07 Foamix Ltd. Penetrating pharmaceutical foam
RU2012126084A (ru) * 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449520A (en) * 1990-07-27 1995-09-12 Giuliani S.P.A. Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
US5725872A (en) * 1993-12-14 1998-03-10 Ferring Bv Composition for foams, notably rectal foams, and foams thus obtained
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US20060275221A1 (en) * 2005-05-09 2006-12-07 Foamix Ltd. Saccharide foamable compositions
WO2009150530A2 (en) * 2008-06-11 2009-12-17 Ferring International Center Sa Novel foam composition
US20110172222A1 (en) * 2008-07-04 2011-07-14 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the Treatment of Inflammatory Conditions of the Gastrointestinal Tract

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALLERGAN LTD: "PACKAGE LEAFLET: INFORMATION FOR THE USERS Asacol Foam Enema", 《HTTP://WWW.MEDICINES.ORG.UK/EMC/FILES/PIL.6755.PDF》 *

Also Published As

Publication number Publication date
AU2017377017A1 (en) 2019-07-04
KR20190110092A (ko) 2019-09-27
JP2022163191A (ja) 2022-10-25
WO2018109717A1 (en) 2018-06-21
RU2757275C2 (ru) 2021-10-12
US20190351060A1 (en) 2019-11-21
MX391415B (es) 2025-03-21
BR112019012122A2 (pt) 2019-11-05
CA3046938A1 (en) 2018-06-21
EP3554473A1 (en) 2019-10-23
IL267347A (en) 2019-08-29
JP2020503296A (ja) 2020-01-30
RU2019119495A3 (https=) 2021-03-24
MX2019006924A (es) 2019-10-09
RU2019119495A (ru) 2021-01-18
MX2021016053A (es) 2022-02-03

Similar Documents

Publication Publication Date Title
ES2209812T3 (es) Pulverizaciones topicas que contienen una composicion filmogena.
JP2566662B2 (ja) 直腸投与用の医薬組成物
JP3776124B2 (ja) 少なくとも一種の糖を含んでなる医薬用エアゾール
JP5184373B2 (ja) 発泡組成物
ES2933479T3 (es) Estabilidad mejorada de formulaciones de progestágenos
AU2010320656B2 (en) Topical foam composition
US20040213744A1 (en) Topical spray compositions
ES2857602T3 (es) Composiciones tópicas de corticosteroides
JPH05504571A (ja) 薬学的用途のための発泡性組成物、その使用および治療方法
PT99340B (pt) Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracao
PT817621E (pt) Composicao farmaceutica formadora de pelicula para administracao transdermica
CA2902852A1 (en) Pharmaceutical compositions for rectal administration
ES2539952T3 (es) Formulaciones esteroideas tópicas
CN110430869A (zh) 直肠泡沫配制物
JP2005533795A (ja) 経皮エアゾール組成物
TWI886312B (zh) 磷脂肌醇3-激酶抑制劑的調配物
AU2004246819A1 (en) Formoterol and ciclesonide combination
JP2001072576A (ja) 経口用医薬品組成物
US20150196488A1 (en) Topical Foam Composition
US20100166672A1 (en) Foam-forming composition
ES2297183T3 (es) Formulaciones de aerosol que contienen esteres de derivados del 3,17-dihidroxi estratrieno para administracion pulmonar.
ZA200400079B (en) Pharmaceutical formulation for the intramuscular administration of fulvestrant.
CN101926767A (zh) 一种布地奈德泡沫剂组合物
Patel Development of Formulations for Uterine Targeting of GnRH Analogue and SERM for the Effective Treatment of Fibroids and Endometriosis via Vaginal Route
CN101926766A (zh) 一种环索奈德泡沫剂组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20230602